Position in RLAY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,644,438
+$4,348,386 QoQ
Shares Held
248,233
+734.3% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. RLAY ranks #70 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,644,438 | 248,233 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $296,052 | 29,754 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $261,667 | 30,930 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $74,718 | 14,314 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $426,938 | 123,393 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $682,018 | 260,313 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $847,383 | 205,676 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $618,692 | 87,386 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $284,205 | 43,590 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,444,307 | 414,977 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,610,354 | 146,263 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,438,816 | 171,084 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,533,426 | 201,706 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $5,865,164 | 356,112 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,126,045 | 209,240 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,066,373 | 181,778 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,118,146 | 186,158 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $935,610 | 31,260 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,901,776 | 159,615 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,232,366 | 134,233 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,508,839 | 123,226 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,730,586 | 107,914 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $408,036 | 9,818 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $65,844 | 1,546 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||